AstraZeneca COVID-19 vaccine induces robust broadly cross-reactive antibody responses in Malawian adults previously infected with SARS-CoV-2



Chibwana, Marah G, Moyo-Gwete, Thandeka, Kwatra, Gaurav, Mandolo, Jonathan, Hermanaus, Tandile, Motlou, Thopisang, Mzindle, Nonkululeko, Ayres, Frances, Chaponda, Mphatso, Tembo, Godwin
et al (show 13 more authors) (2022) AstraZeneca COVID-19 vaccine induces robust broadly cross-reactive antibody responses in Malawian adults previously infected with SARS-CoV-2. BMC MEDICINE, 20 (1).

Access the full-text of this item by clicking on the Open Access link.
Item Type: Article
Uncontrolled Keywords: Antibodies, AstraZeneca COVID-19 vaccine, RBD, SARS-CoV-2, Spike, VOC
Divisions: Faculty of Health and Life Sciences
Faculty of Health and Life Sciences > Institute of Infection, Veterinary and Ecological Sciences
Faculty of Health and Life Sciences > Institute of Life Courses and Medical Sciences
Depositing User: Symplectic Admin
Date Deposited: 04 May 2022 09:47
Last Modified: 11 Aug 2022 11:33
DOI: 10.1186/s12916-022-02342-z
Open Access URL: https://doi.org/10.1186/s12916-022-02342-z
Related URLs:
URI: https://livrepository.liverpool.ac.uk/id/eprint/3154269